Medical Care
Global Hospital-Acquired Disease Testing Market Research Report 2024
- Jan 26, 24
- ID: 28847
- Pages: 74
- Figures: 134
- Views: 27
Hospital acquired infections/diseases (HAIs) or nosocomial infections are defined to the infection acquired by patients during their stay in healthcare settings. Approximately 9.2 out of 100 patients in the U.S. acquire HAI. The most common types of HAIs include pneumonia, urinary tract infection, bloodstream infection, surgical site infection and others. HAIs are caused by pathogens among patients with compromised immune system, and negligence by hospital staff. The significant morbidity and mortality, the associated management costs and growing pressure from governing bodies have urged care-givers to devise accurate diagnosis of HAIs for efficient healthcare provision.
The global Hospital-Acquired Disease Testing market was valued at US$ 492.3 million in 2023 and is anticipated to reach US$ 706.1 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Hospital-Acquired Disease Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital-Acquired Disease Testing.
Report Scope
The Hospital-Acquired Disease Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hospital-Acquired Disease Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hospital-Acquired Disease Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Diatherix Laboratories
Gen-Probe
Qiagen
F. Hoffmann-La Roche
Cepheid
Life Technologies Corporation
Meridian Biosciences
Cantel Medical Corporation
Nordion
Segment by Type
UTI Testing
SSI Testing
Pneumococcal Infections Testing
Bloodstream Infections Testing
MRSA Testing
Segment by Application
Small and Medium Sized Hospitals
Large Sized Hospitals
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hospital-Acquired Disease Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Hospital-Acquired Disease Testing market was valued at US$ 492.3 million in 2023 and is anticipated to reach US$ 706.1 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Hospital-Acquired Disease Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital-Acquired Disease Testing.
Report Scope
The Hospital-Acquired Disease Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hospital-Acquired Disease Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hospital-Acquired Disease Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Diatherix Laboratories
Gen-Probe
Qiagen
F. Hoffmann-La Roche
Cepheid
Life Technologies Corporation
Meridian Biosciences
Cantel Medical Corporation
Nordion
Segment by Type
UTI Testing
SSI Testing
Pneumococcal Infections Testing
Bloodstream Infections Testing
MRSA Testing
Segment by Application
Small and Medium Sized Hospitals
Large Sized Hospitals
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hospital-Acquired Disease Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital-Acquired Disease Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 UTI Testing
1.2.3 SSI Testing
1.2.4 Pneumococcal Infections Testing
1.2.5 Bloodstream Infections Testing
1.2.6 MRSA Testing
1.3 Market by Application
1.3.1 Global Hospital-Acquired Disease Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Small and Medium Sized Hospitals
1.3.3 Large Sized Hospitals
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hospital-Acquired Disease Testing Market Perspective (2019-2030)
2.2 Hospital-Acquired Disease Testing Growth Trends by Region
2.2.1 Global Hospital-Acquired Disease Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hospital-Acquired Disease Testing Historic Market Size by Region (2019-2024)
2.2.3 Hospital-Acquired Disease Testing Forecasted Market Size by Region (2025-2030)
2.3 Hospital-Acquired Disease Testing Market Dynamics
2.3.1 Hospital-Acquired Disease Testing Industry Trends
2.3.2 Hospital-Acquired Disease Testing Market Drivers
2.3.3 Hospital-Acquired Disease Testing Market Challenges
2.3.4 Hospital-Acquired Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hospital-Acquired Disease Testing Players by Revenue
3.1.1 Global Top Hospital-Acquired Disease Testing Players by Revenue (2019-2024)
3.1.2 Global Hospital-Acquired Disease Testing Revenue Market Share by Players (2019-2024)
3.2 Global Hospital-Acquired Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hospital-Acquired Disease Testing Revenue
3.4 Global Hospital-Acquired Disease Testing Market Concentration Ratio
3.4.1 Global Hospital-Acquired Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital-Acquired Disease Testing Revenue in 2023
3.5 Hospital-Acquired Disease Testing Key Players Head office and Area Served
3.6 Key Players Hospital-Acquired Disease Testing Product Solution and Service
3.7 Date of Enter into Hospital-Acquired Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hospital-Acquired Disease Testing Breakdown Data by Type
4.1 Global Hospital-Acquired Disease Testing Historic Market Size by Type (2019-2024)
4.2 Global Hospital-Acquired Disease Testing Forecasted Market Size by Type (2025-2030)
5 Hospital-Acquired Disease Testing Breakdown Data by Application
5.1 Global Hospital-Acquired Disease Testing Historic Market Size by Application (2019-2024)
5.2 Global Hospital-Acquired Disease Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hospital-Acquired Disease Testing Market Size (2019-2030)
6.2 North America Hospital-Acquired Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hospital-Acquired Disease Testing Market Size by Country (2019-2024)
6.4 North America Hospital-Acquired Disease Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hospital-Acquired Disease Testing Market Size (2019-2030)
7.2 Europe Hospital-Acquired Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hospital-Acquired Disease Testing Market Size by Country (2019-2024)
7.4 Europe Hospital-Acquired Disease Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hospital-Acquired Disease Testing Market Size (2019-2030)
8.2 Asia-Pacific Hospital-Acquired Disease Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hospital-Acquired Disease Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Hospital-Acquired Disease Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hospital-Acquired Disease Testing Market Size (2019-2030)
9.2 Latin America Hospital-Acquired Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hospital-Acquired Disease Testing Market Size by Country (2019-2024)
9.4 Latin America Hospital-Acquired Disease Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hospital-Acquired Disease Testing Market Size (2019-2030)
10.2 Middle East & Africa Hospital-Acquired Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hospital-Acquired Disease Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Hospital-Acquired Disease Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Diatherix Laboratories
11.1.1 Diatherix Laboratories Company Detail
11.1.2 Diatherix Laboratories Business Overview
11.1.3 Diatherix Laboratories Hospital-Acquired Disease Testing Introduction
11.1.4 Diatherix Laboratories Revenue in Hospital-Acquired Disease Testing Business (2019-2024)
11.1.5 Diatherix Laboratories Recent Development
11.2 Gen-Probe
11.2.1 Gen-Probe Company Detail
11.2.2 Gen-Probe Business Overview
11.2.3 Gen-Probe Hospital-Acquired Disease Testing Introduction
11.2.4 Gen-Probe Revenue in Hospital-Acquired Disease Testing Business (2019-2024)
11.2.5 Gen-Probe Recent Development
11.3 Qiagen
11.3.1 Qiagen Company Detail
11.3.2 Qiagen Business Overview
11.3.3 Qiagen Hospital-Acquired Disease Testing Introduction
11.3.4 Qiagen Revenue in Hospital-Acquired Disease Testing Business (2019-2024)
11.3.5 Qiagen Recent Development
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Detail
11.4.2 F. Hoffmann-La Roche Business Overview
11.4.3 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Introduction
11.4.4 F. Hoffmann-La Roche Revenue in Hospital-Acquired Disease Testing Business (2019-2024)
11.4.5 F. Hoffmann-La Roche Recent Development
11.5 Cepheid
11.5.1 Cepheid Company Detail
11.5.2 Cepheid Business Overview
11.5.3 Cepheid Hospital-Acquired Disease Testing Introduction
11.5.4 Cepheid Revenue in Hospital-Acquired Disease Testing Business (2019-2024)
11.5.5 Cepheid Recent Development
11.6 Life Technologies Corporation
11.6.1 Life Technologies Corporation Company Detail
11.6.2 Life Technologies Corporation Business Overview
11.6.3 Life Technologies Corporation Hospital-Acquired Disease Testing Introduction
11.6.4 Life Technologies Corporation Revenue in Hospital-Acquired Disease Testing Business (2019-2024)
11.6.5 Life Technologies Corporation Recent Development
11.7 Meridian Biosciences
11.7.1 Meridian Biosciences Company Detail
11.7.2 Meridian Biosciences Business Overview
11.7.3 Meridian Biosciences Hospital-Acquired Disease Testing Introduction
11.7.4 Meridian Biosciences Revenue in Hospital-Acquired Disease Testing Business (2019-2024)
11.7.5 Meridian Biosciences Recent Development
11.8 Cantel Medical Corporation
11.8.1 Cantel Medical Corporation Company Detail
11.8.2 Cantel Medical Corporation Business Overview
11.8.3 Cantel Medical Corporation Hospital-Acquired Disease Testing Introduction
11.8.4 Cantel Medical Corporation Revenue in Hospital-Acquired Disease Testing Business (2019-2024)
11.8.5 Cantel Medical Corporation Recent Development
11.9 Nordion
11.9.1 Nordion Company Detail
11.9.2 Nordion Business Overview
11.9.3 Nordion Hospital-Acquired Disease Testing Introduction
11.9.4 Nordion Revenue in Hospital-Acquired Disease Testing Business (2019-2024)
11.9.5 Nordion Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital-Acquired Disease Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 UTI Testing
1.2.3 SSI Testing
1.2.4 Pneumococcal Infections Testing
1.2.5 Bloodstream Infections Testing
1.2.6 MRSA Testing
1.3 Market by Application
1.3.1 Global Hospital-Acquired Disease Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Small and Medium Sized Hospitals
1.3.3 Large Sized Hospitals
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hospital-Acquired Disease Testing Market Perspective (2019-2030)
2.2 Hospital-Acquired Disease Testing Growth Trends by Region
2.2.1 Global Hospital-Acquired Disease Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hospital-Acquired Disease Testing Historic Market Size by Region (2019-2024)
2.2.3 Hospital-Acquired Disease Testing Forecasted Market Size by Region (2025-2030)
2.3 Hospital-Acquired Disease Testing Market Dynamics
2.3.1 Hospital-Acquired Disease Testing Industry Trends
2.3.2 Hospital-Acquired Disease Testing Market Drivers
2.3.3 Hospital-Acquired Disease Testing Market Challenges
2.3.4 Hospital-Acquired Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hospital-Acquired Disease Testing Players by Revenue
3.1.1 Global Top Hospital-Acquired Disease Testing Players by Revenue (2019-2024)
3.1.2 Global Hospital-Acquired Disease Testing Revenue Market Share by Players (2019-2024)
3.2 Global Hospital-Acquired Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hospital-Acquired Disease Testing Revenue
3.4 Global Hospital-Acquired Disease Testing Market Concentration Ratio
3.4.1 Global Hospital-Acquired Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital-Acquired Disease Testing Revenue in 2023
3.5 Hospital-Acquired Disease Testing Key Players Head office and Area Served
3.6 Key Players Hospital-Acquired Disease Testing Product Solution and Service
3.7 Date of Enter into Hospital-Acquired Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hospital-Acquired Disease Testing Breakdown Data by Type
4.1 Global Hospital-Acquired Disease Testing Historic Market Size by Type (2019-2024)
4.2 Global Hospital-Acquired Disease Testing Forecasted Market Size by Type (2025-2030)
5 Hospital-Acquired Disease Testing Breakdown Data by Application
5.1 Global Hospital-Acquired Disease Testing Historic Market Size by Application (2019-2024)
5.2 Global Hospital-Acquired Disease Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hospital-Acquired Disease Testing Market Size (2019-2030)
6.2 North America Hospital-Acquired Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hospital-Acquired Disease Testing Market Size by Country (2019-2024)
6.4 North America Hospital-Acquired Disease Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hospital-Acquired Disease Testing Market Size (2019-2030)
7.2 Europe Hospital-Acquired Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hospital-Acquired Disease Testing Market Size by Country (2019-2024)
7.4 Europe Hospital-Acquired Disease Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hospital-Acquired Disease Testing Market Size (2019-2030)
8.2 Asia-Pacific Hospital-Acquired Disease Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hospital-Acquired Disease Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Hospital-Acquired Disease Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hospital-Acquired Disease Testing Market Size (2019-2030)
9.2 Latin America Hospital-Acquired Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hospital-Acquired Disease Testing Market Size by Country (2019-2024)
9.4 Latin America Hospital-Acquired Disease Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hospital-Acquired Disease Testing Market Size (2019-2030)
10.2 Middle East & Africa Hospital-Acquired Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hospital-Acquired Disease Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Hospital-Acquired Disease Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Diatherix Laboratories
11.1.1 Diatherix Laboratories Company Detail
11.1.2 Diatherix Laboratories Business Overview
11.1.3 Diatherix Laboratories Hospital-Acquired Disease Testing Introduction
11.1.4 Diatherix Laboratories Revenue in Hospital-Acquired Disease Testing Business (2019-2024)
11.1.5 Diatherix Laboratories Recent Development
11.2 Gen-Probe
11.2.1 Gen-Probe Company Detail
11.2.2 Gen-Probe Business Overview
11.2.3 Gen-Probe Hospital-Acquired Disease Testing Introduction
11.2.4 Gen-Probe Revenue in Hospital-Acquired Disease Testing Business (2019-2024)
11.2.5 Gen-Probe Recent Development
11.3 Qiagen
11.3.1 Qiagen Company Detail
11.3.2 Qiagen Business Overview
11.3.3 Qiagen Hospital-Acquired Disease Testing Introduction
11.3.4 Qiagen Revenue in Hospital-Acquired Disease Testing Business (2019-2024)
11.3.5 Qiagen Recent Development
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Detail
11.4.2 F. Hoffmann-La Roche Business Overview
11.4.3 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Introduction
11.4.4 F. Hoffmann-La Roche Revenue in Hospital-Acquired Disease Testing Business (2019-2024)
11.4.5 F. Hoffmann-La Roche Recent Development
11.5 Cepheid
11.5.1 Cepheid Company Detail
11.5.2 Cepheid Business Overview
11.5.3 Cepheid Hospital-Acquired Disease Testing Introduction
11.5.4 Cepheid Revenue in Hospital-Acquired Disease Testing Business (2019-2024)
11.5.5 Cepheid Recent Development
11.6 Life Technologies Corporation
11.6.1 Life Technologies Corporation Company Detail
11.6.2 Life Technologies Corporation Business Overview
11.6.3 Life Technologies Corporation Hospital-Acquired Disease Testing Introduction
11.6.4 Life Technologies Corporation Revenue in Hospital-Acquired Disease Testing Business (2019-2024)
11.6.5 Life Technologies Corporation Recent Development
11.7 Meridian Biosciences
11.7.1 Meridian Biosciences Company Detail
11.7.2 Meridian Biosciences Business Overview
11.7.3 Meridian Biosciences Hospital-Acquired Disease Testing Introduction
11.7.4 Meridian Biosciences Revenue in Hospital-Acquired Disease Testing Business (2019-2024)
11.7.5 Meridian Biosciences Recent Development
11.8 Cantel Medical Corporation
11.8.1 Cantel Medical Corporation Company Detail
11.8.2 Cantel Medical Corporation Business Overview
11.8.3 Cantel Medical Corporation Hospital-Acquired Disease Testing Introduction
11.8.4 Cantel Medical Corporation Revenue in Hospital-Acquired Disease Testing Business (2019-2024)
11.8.5 Cantel Medical Corporation Recent Development
11.9 Nordion
11.9.1 Nordion Company Detail
11.9.2 Nordion Business Overview
11.9.3 Nordion Hospital-Acquired Disease Testing Introduction
11.9.4 Nordion Revenue in Hospital-Acquired Disease Testing Business (2019-2024)
11.9.5 Nordion Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Hospital-Acquired Disease Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of UTI Testing
Table 3. Key Players of SSI Testing
Table 4. Key Players of Pneumococcal Infections Testing
Table 5. Key Players of Bloodstream Infections Testing
Table 6. Key Players of MRSA Testing
Table 7. Global Hospital-Acquired Disease Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Hospital-Acquired Disease Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Hospital-Acquired Disease Testing Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Hospital-Acquired Disease Testing Market Share by Region (2019-2024)
Table 11. Global Hospital-Acquired Disease Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Hospital-Acquired Disease Testing Market Share by Region (2025-2030)
Table 13. Hospital-Acquired Disease Testing Market Trends
Table 14. Hospital-Acquired Disease Testing Market Drivers
Table 15. Hospital-Acquired Disease Testing Market Challenges
Table 16. Hospital-Acquired Disease Testing Market Restraints
Table 17. Global Hospital-Acquired Disease Testing Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Hospital-Acquired Disease Testing Market Share by Players (2019-2024)
Table 19. Global Top Hospital-Acquired Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital-Acquired Disease Testing as of 2023)
Table 20. Ranking of Global Top Hospital-Acquired Disease Testing Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Hospital-Acquired Disease Testing Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Hospital-Acquired Disease Testing Product Solution and Service
Table 24. Date of Enter into Hospital-Acquired Disease Testing Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hospital-Acquired Disease Testing Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Hospital-Acquired Disease Testing Revenue Market Share by Type (2019-2024)
Table 28. Global Hospital-Acquired Disease Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Hospital-Acquired Disease Testing Revenue Market Share by Type (2025-2030)
Table 30. Global Hospital-Acquired Disease Testing Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Hospital-Acquired Disease Testing Revenue Market Share by Application (2019-2024)
Table 32. Global Hospital-Acquired Disease Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Hospital-Acquired Disease Testing Revenue Market Share by Application (2025-2030)
Table 34. North America Hospital-Acquired Disease Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Hospital-Acquired Disease Testing Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Hospital-Acquired Disease Testing Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Hospital-Acquired Disease Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Hospital-Acquired Disease Testing Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Hospital-Acquired Disease Testing Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Hospital-Acquired Disease Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Hospital-Acquired Disease Testing Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Hospital-Acquired Disease Testing Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Hospital-Acquired Disease Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Hospital-Acquired Disease Testing Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Hospital-Acquired Disease Testing Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Hospital-Acquired Disease Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Hospital-Acquired Disease Testing Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Hospital-Acquired Disease Testing Market Size by Country (2025-2030) & (US$ Million)
Table 49. Diatherix Laboratories Company Detail
Table 50. Diatherix Laboratories Business Overview
Table 51. Diatherix Laboratories Hospital-Acquired Disease Testing Product
Table 52. Diatherix Laboratories Revenue in Hospital-Acquired Disease Testing Business (2019-2024) & (US$ Million)
Table 53. Diatherix Laboratories Recent Development
Table 54. Gen-Probe Company Detail
Table 55. Gen-Probe Business Overview
Table 56. Gen-Probe Hospital-Acquired Disease Testing Product
Table 57. Gen-Probe Revenue in Hospital-Acquired Disease Testing Business (2019-2024) & (US$ Million)
Table 58. Gen-Probe Recent Development
Table 59. Qiagen Company Detail
Table 60. Qiagen Business Overview
Table 61. Qiagen Hospital-Acquired Disease Testing Product
Table 62. Qiagen Revenue in Hospital-Acquired Disease Testing Business (2019-2024) & (US$ Million)
Table 63. Qiagen Recent Development
Table 64. F. Hoffmann-La Roche Company Detail
Table 65. F. Hoffmann-La Roche Business Overview
Table 66. F. Hoffmann-La Roche Hospital-Acquired Disease Testing Product
Table 67. F. Hoffmann-La Roche Revenue in Hospital-Acquired Disease Testing Business (2019-2024) & (US$ Million)
Table 68. F. Hoffmann-La Roche Recent Development
Table 69. Cepheid Company Detail
Table 70. Cepheid Business Overview
Table 71. Cepheid Hospital-Acquired Disease Testing Product
Table 72. Cepheid Revenue in Hospital-Acquired Disease Testing Business (2019-2024) & (US$ Million)
Table 73. Cepheid Recent Development
Table 74. Life Technologies Corporation Company Detail
Table 75. Life Technologies Corporation Business Overview
Table 76. Life Technologies Corporation Hospital-Acquired Disease Testing Product
Table 77. Life Technologies Corporation Revenue in Hospital-Acquired Disease Testing Business (2019-2024) & (US$ Million)
Table 78. Life Technologies Corporation Recent Development
Table 79. Meridian Biosciences Company Detail
Table 80. Meridian Biosciences Business Overview
Table 81. Meridian Biosciences Hospital-Acquired Disease Testing Product
Table 82. Meridian Biosciences Revenue in Hospital-Acquired Disease Testing Business (2019-2024) & (US$ Million)
Table 83. Meridian Biosciences Recent Development
Table 84. Cantel Medical Corporation Company Detail
Table 85. Cantel Medical Corporation Business Overview
Table 86. Cantel Medical Corporation Hospital-Acquired Disease Testing Product
Table 87. Cantel Medical Corporation Revenue in Hospital-Acquired Disease Testing Business (2019-2024) & (US$ Million)
Table 88. Cantel Medical Corporation Recent Development
Table 89. Nordion Company Detail
Table 90. Nordion Business Overview
Table 91. Nordion Hospital-Acquired Disease Testing Product
Table 92. Nordion Revenue in Hospital-Acquired Disease Testing Business (2019-2024) & (US$ Million)
Table 93. Nordion Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hospital-Acquired Disease Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Hospital-Acquired Disease Testing Market Share by Type: 2023 VS 2030
Figure 3. UTI Testing Features
Figure 4. SSI Testing Features
Figure 5. Pneumococcal Infections Testing Features
Figure 6. Bloodstream Infections Testing Features
Figure 7. MRSA Testing Features
Figure 8. Global Hospital-Acquired Disease Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Hospital-Acquired Disease Testing Market Share by Application: 2023 VS 2030
Figure 10. Small and Medium Sized Hospitals Case Studies
Figure 11. Large Sized Hospitals Case Studies
Figure 12. Hospital-Acquired Disease Testing Report Years Considered
Figure 13. Global Hospital-Acquired Disease Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Hospital-Acquired Disease Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Hospital-Acquired Disease Testing Market Share by Region: 2023 VS 2030
Figure 16. Global Hospital-Acquired Disease Testing Market Share by Players in 2023
Figure 17. Global Top Hospital-Acquired Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital-Acquired Disease Testing as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Hospital-Acquired Disease Testing Revenue in 2023
Figure 19. North America Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Hospital-Acquired Disease Testing Market Share by Country (2019-2030)
Figure 21. United States Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Hospital-Acquired Disease Testing Market Share by Country (2019-2030)
Figure 25. Germany Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Hospital-Acquired Disease Testing Market Share by Region (2019-2030)
Figure 33. China Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Hospital-Acquired Disease Testing Market Share by Country (2019-2030)
Figure 41. Mexico Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Hospital-Acquired Disease Testing Market Share by Country (2019-2030)
Figure 45. Turkey Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Diatherix Laboratories Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2019-2024)
Figure 48. Gen-Probe Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2019-2024)
Figure 49. Qiagen Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2019-2024)
Figure 50. F. Hoffmann-La Roche Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2019-2024)
Figure 51. Cepheid Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2019-2024)
Figure 52. Life Technologies Corporation Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2019-2024)
Figure 53. Meridian Biosciences Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2019-2024)
Figure 54. Cantel Medical Corporation Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2019-2024)
Figure 55. Nordion Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Table 1. Global Hospital-Acquired Disease Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of UTI Testing
Table 3. Key Players of SSI Testing
Table 4. Key Players of Pneumococcal Infections Testing
Table 5. Key Players of Bloodstream Infections Testing
Table 6. Key Players of MRSA Testing
Table 7. Global Hospital-Acquired Disease Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Hospital-Acquired Disease Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Hospital-Acquired Disease Testing Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Hospital-Acquired Disease Testing Market Share by Region (2019-2024)
Table 11. Global Hospital-Acquired Disease Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Hospital-Acquired Disease Testing Market Share by Region (2025-2030)
Table 13. Hospital-Acquired Disease Testing Market Trends
Table 14. Hospital-Acquired Disease Testing Market Drivers
Table 15. Hospital-Acquired Disease Testing Market Challenges
Table 16. Hospital-Acquired Disease Testing Market Restraints
Table 17. Global Hospital-Acquired Disease Testing Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Hospital-Acquired Disease Testing Market Share by Players (2019-2024)
Table 19. Global Top Hospital-Acquired Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital-Acquired Disease Testing as of 2023)
Table 20. Ranking of Global Top Hospital-Acquired Disease Testing Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Hospital-Acquired Disease Testing Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Hospital-Acquired Disease Testing Product Solution and Service
Table 24. Date of Enter into Hospital-Acquired Disease Testing Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hospital-Acquired Disease Testing Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Hospital-Acquired Disease Testing Revenue Market Share by Type (2019-2024)
Table 28. Global Hospital-Acquired Disease Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Hospital-Acquired Disease Testing Revenue Market Share by Type (2025-2030)
Table 30. Global Hospital-Acquired Disease Testing Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Hospital-Acquired Disease Testing Revenue Market Share by Application (2019-2024)
Table 32. Global Hospital-Acquired Disease Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Hospital-Acquired Disease Testing Revenue Market Share by Application (2025-2030)
Table 34. North America Hospital-Acquired Disease Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Hospital-Acquired Disease Testing Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Hospital-Acquired Disease Testing Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Hospital-Acquired Disease Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Hospital-Acquired Disease Testing Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Hospital-Acquired Disease Testing Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Hospital-Acquired Disease Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Hospital-Acquired Disease Testing Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Hospital-Acquired Disease Testing Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Hospital-Acquired Disease Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Hospital-Acquired Disease Testing Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Hospital-Acquired Disease Testing Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Hospital-Acquired Disease Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Hospital-Acquired Disease Testing Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Hospital-Acquired Disease Testing Market Size by Country (2025-2030) & (US$ Million)
Table 49. Diatherix Laboratories Company Detail
Table 50. Diatherix Laboratories Business Overview
Table 51. Diatherix Laboratories Hospital-Acquired Disease Testing Product
Table 52. Diatherix Laboratories Revenue in Hospital-Acquired Disease Testing Business (2019-2024) & (US$ Million)
Table 53. Diatherix Laboratories Recent Development
Table 54. Gen-Probe Company Detail
Table 55. Gen-Probe Business Overview
Table 56. Gen-Probe Hospital-Acquired Disease Testing Product
Table 57. Gen-Probe Revenue in Hospital-Acquired Disease Testing Business (2019-2024) & (US$ Million)
Table 58. Gen-Probe Recent Development
Table 59. Qiagen Company Detail
Table 60. Qiagen Business Overview
Table 61. Qiagen Hospital-Acquired Disease Testing Product
Table 62. Qiagen Revenue in Hospital-Acquired Disease Testing Business (2019-2024) & (US$ Million)
Table 63. Qiagen Recent Development
Table 64. F. Hoffmann-La Roche Company Detail
Table 65. F. Hoffmann-La Roche Business Overview
Table 66. F. Hoffmann-La Roche Hospital-Acquired Disease Testing Product
Table 67. F. Hoffmann-La Roche Revenue in Hospital-Acquired Disease Testing Business (2019-2024) & (US$ Million)
Table 68. F. Hoffmann-La Roche Recent Development
Table 69. Cepheid Company Detail
Table 70. Cepheid Business Overview
Table 71. Cepheid Hospital-Acquired Disease Testing Product
Table 72. Cepheid Revenue in Hospital-Acquired Disease Testing Business (2019-2024) & (US$ Million)
Table 73. Cepheid Recent Development
Table 74. Life Technologies Corporation Company Detail
Table 75. Life Technologies Corporation Business Overview
Table 76. Life Technologies Corporation Hospital-Acquired Disease Testing Product
Table 77. Life Technologies Corporation Revenue in Hospital-Acquired Disease Testing Business (2019-2024) & (US$ Million)
Table 78. Life Technologies Corporation Recent Development
Table 79. Meridian Biosciences Company Detail
Table 80. Meridian Biosciences Business Overview
Table 81. Meridian Biosciences Hospital-Acquired Disease Testing Product
Table 82. Meridian Biosciences Revenue in Hospital-Acquired Disease Testing Business (2019-2024) & (US$ Million)
Table 83. Meridian Biosciences Recent Development
Table 84. Cantel Medical Corporation Company Detail
Table 85. Cantel Medical Corporation Business Overview
Table 86. Cantel Medical Corporation Hospital-Acquired Disease Testing Product
Table 87. Cantel Medical Corporation Revenue in Hospital-Acquired Disease Testing Business (2019-2024) & (US$ Million)
Table 88. Cantel Medical Corporation Recent Development
Table 89. Nordion Company Detail
Table 90. Nordion Business Overview
Table 91. Nordion Hospital-Acquired Disease Testing Product
Table 92. Nordion Revenue in Hospital-Acquired Disease Testing Business (2019-2024) & (US$ Million)
Table 93. Nordion Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hospital-Acquired Disease Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Hospital-Acquired Disease Testing Market Share by Type: 2023 VS 2030
Figure 3. UTI Testing Features
Figure 4. SSI Testing Features
Figure 5. Pneumococcal Infections Testing Features
Figure 6. Bloodstream Infections Testing Features
Figure 7. MRSA Testing Features
Figure 8. Global Hospital-Acquired Disease Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Hospital-Acquired Disease Testing Market Share by Application: 2023 VS 2030
Figure 10. Small and Medium Sized Hospitals Case Studies
Figure 11. Large Sized Hospitals Case Studies
Figure 12. Hospital-Acquired Disease Testing Report Years Considered
Figure 13. Global Hospital-Acquired Disease Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Hospital-Acquired Disease Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Hospital-Acquired Disease Testing Market Share by Region: 2023 VS 2030
Figure 16. Global Hospital-Acquired Disease Testing Market Share by Players in 2023
Figure 17. Global Top Hospital-Acquired Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital-Acquired Disease Testing as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Hospital-Acquired Disease Testing Revenue in 2023
Figure 19. North America Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Hospital-Acquired Disease Testing Market Share by Country (2019-2030)
Figure 21. United States Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Hospital-Acquired Disease Testing Market Share by Country (2019-2030)
Figure 25. Germany Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Hospital-Acquired Disease Testing Market Share by Region (2019-2030)
Figure 33. China Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Hospital-Acquired Disease Testing Market Share by Country (2019-2030)
Figure 41. Mexico Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Hospital-Acquired Disease Testing Market Share by Country (2019-2030)
Figure 45. Turkey Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Hospital-Acquired Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Diatherix Laboratories Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2019-2024)
Figure 48. Gen-Probe Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2019-2024)
Figure 49. Qiagen Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2019-2024)
Figure 50. F. Hoffmann-La Roche Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2019-2024)
Figure 51. Cepheid Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2019-2024)
Figure 52. Life Technologies Corporation Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2019-2024)
Figure 53. Meridian Biosciences Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2019-2024)
Figure 54. Cantel Medical Corporation Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2019-2024)
Figure 55. Nordion Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232